Thinking of joining a study?

Register your interest

Become a volunteer?

NCT03572374 | RECRUITING | Breast Cancer

Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job
Sponsor:

Memorial Sloan Kettering Cancer Center

Brief Summary:

The purpose of this study is learn more about how being treated for breast cancer affects patients' employment. Researchers are testing an early version of a mobile app designed to help breast cancer patients keep their jobs during and after treatment. The app provides advice for patients to use when having conversations about breast cancer with their employers and their doctors. The app is called TEAMWork (Talking to Employers And Medical staff about Work). In this study, the investigators are asking breast cancer patients who are about to receive treatment or who are currently receiving treatment to tell us what aspects of the app work well, so that they can learn how to improve it.

Condition or disease

Breast Cancer

Intervention/treatment

TEAMWork App

Information Booklet

Phase

NA

Study Type : INTERVENTIONAL
Estimated Enrollment : 546 participants
Masking : NONE
Primary Purpose : SUPPORTIVE_CARE
Official Title : Breast Cancer and the Workforce: Talking to Employers and Medical Staff About Work (TEAMWork)
Actual Study Start Date : 2018-06-07
Estimated Primary Completion Date : 2026-06
Estimated Study Completion Date : 2026-06

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: FEMALE
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • Patient Usability Testing Inclusion Criteria
    • * History of a cancer diagnosis
    • * At least 18 years of age
    • * Male or Female
    • * The ability to give informed consent in English or Spanish
    • * Able to use and read a smartphone (iPhone or Android)
    • * Has a smartphone (iPhone or Android)
    • Community Usability Testing Inclusion Criteria
      • * At least 18 years of age
      • * Male or Female
      • * The ability to give informed consent in English or Spanish
      • * Able to use and read a smartphone (iPhone or Android)
      • * Has a smartphone (iPhone or Android)
      • Focus Group and Interview Inclusion Criteria
        • * Completed chemotherapy treatment for stage I-III breast cancer.
        • * Age 18 to 64 (inclusive)
        • * Female
        • * Paid employment (full time or part time) in the three months prior to diagnosis or at time of consent to MSK protocol #10-071 (PI: Blinder)
        • * The ability to give informed consent in English or Spanish
        • * Able to use and read a smartphone (iPhone or Android)
        • * Has a smartphone (iPhone or Android)
        • For Cohort 2
          • * Participants was covered by Emergency Medicaid at the time of diagnosis and/or at any point during their treatment for breast cancer
          • RCT Inclusion Criteria
            • * Localized invasive breast cancer (not stage 0 or stage IV) per EMR or breast cancer (not stage 0 or stage IV) per self-report for community participants
            • * If electronic medical record does not specify stage and patient is undergoing (neo)adjuvant chemotherapy, assume stage is I, II or III
            • * Planning to undergo or undergoing adjuvant or neoadjuvant chemotherapy per EMR or planning to undergo or undergo chemotherapy per self-report for community participants
            • * Age 18 to 64 (inclusive)
            • * Female
            • * Employment statue of (full time or part time) (those who are on disability leave/medical leave, and other unique employment circumstances at the PI's dicretion are eligible)
            • * Language preference as English or Spanish
            • * Able to use and read a smartphone or tablet (e.g. iPad, iPhone or Android)
            • * Has access to a smartphone or tablet (e.g. iPad, iPhone or Android)
            Exclusion Criteria
            • RCT Exclusion Criteria
              • * Stage 0 breast cancer (DCIS only)
              • * Stage IV (metastatic) breast cancer
              • * Recurrence with metastases of breast cancer
              • * Participants or family members who are participating in MSK IHCD studies related to social determinants of health
Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job

Location Details

NCT03572374

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

RECRUITING

United States, New Jersey

Memorial Sloan Kettering Basking Ridge (Consent and Follow-up)

Basking Ridge, New Jersey, United States, 07920

RECRUITING

United States, New Jersey

Memorial Sloan Kettering Monmouth (Consent and Follow-up)

Middletown, New Jersey, United States, 07748

RECRUITING

United States, New Jersey

Memorial Sloan Kettering Bergen (Consent and Follow up)

Montvale, New Jersey, United States, 07645

ACTIVE NOT RECRUITING

United States, New York

Lincoln Medical and Mental Health Center

Bronx, New York, United States, 10451

RECRUITING

United States, New York

Montefiore Medical Center

Bronx, New York, United States, 10467

RECRUITING

United States, New York

Memorial Sloan Kettering Westchester (Consent and Follow-up)

Harrison, New York, United States, 10604

RECRUITING

United States, New York

Queens Cancer Center of Queens Hospital

Jamaica, New York, United States, 11432

NOT YET RECRUITING

United States, New York

Bellevue Hospital Center (Data Collection Only)

New York, New York, United States, 10016

RECRUITING

United States, New York

Memorial Sloan Kettering Cancer Center

New York, New York, United States, 10065